Article info

Download PDFPDF
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia
  1. Correspondence to:
 Dr C Douglass
 Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK; chris.douglass{at}sth.nhs.uk
View Full Text

Citation

Douglass C, Suvarna K, Reilly MM, et al
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia

Publication history

  • Accepted July 9, 2006
  • First published September 13, 2006.
Online issue publication 
January 16, 2007

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.